Clinical trials
Phase 4 Neoplasm Metastasis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xu jianmin | 2 |
| Fudan University | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Kyowa Kirin China Pharmaceutical Co., Ltd. | 1 |
| Qianfoshan Hospital | 1 |
| Qidong Gaitianli Medicines Co., Ltd | 1 |
| Ye Xu | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 8 |
| Colorectal Neoplasms | 4 |
| Liver Neoplasms | 2 |
| Recurrence | 2 |
| Carcinoma, Hepatocellular | 1 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 |
| Hyperparathyroidism | 1 |
| Hyperparathyroidism, Secondary | 1 |
| Thyroid Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.